Cost-Effectiveness Analysis of Hemoptysis Therapies Among Hospitalized Patients at Persahabatan Hospital
Persahabatan Respirology Journal · 30.06.2026 · 2 (1) · 44
DOI: 10.67483/prj.v2.i1.23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Persahabatan Respirology Journal, online erschienen am 30.06.2026. Verfasst von Asri Nurfita Astuti und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Carbazochrome has not been included in the Indonesian National Formulary(FORNAS), which serves as a prescribing guideline for patients covered by the NationalHealth Insurance program (JKN). However, Persahabatan Hospital issued a Director’sDecree on January 18, 2024, permitting the use of carbazochrome for patients withmassive hemoptysis or for those who did not respond to tranexamic acid after three days oftreatment. This study aimed to analyze the cost-effectiveness of hemoptysis therapy inhospitalized patients at Persahabatan Hospital. A retrospective cohort study was conductedusing medical records of hospitalized patients with hemoptysis from January to June 2024.
Methods
Therapeutic effectiveness was assessed based on the time to bleedingcessation (days), while costs were calculated from total direct medical costs. Costeffectivenessanalysis was subsequently performed. The non-parametric Kruskal–Wallistest was used to compare therapeutic effectiveness and total direct medical costs amongthe three treatment groups.
Results
The results showed no significant differences in sex, age, diagnosis, therapeuticeffectiveness, or total direct medical costs among the treatment groups. However, therewas a significant difference in the proportion of patients with massive hemoptysis amongthe three groups (p=0.040), indicating differences in baseline disease severity.
Conclusion
There were no significant differences in sociodemographic profiles,therapeutic effectiveness, or total direct medical costs among the three treatment groups.
Zitieren
APA
Astuti, A. N., Kusumaeni, T., Paramitha, Y., Andriyanto, D. B., & Nurhayati, F. (2026). Cost-Effectiveness Analysis of Hemoptysis Therapies Among Hospitalized Patients at Persahabatan Hospital. Persahabatan Respirology Journal, 2(1), 44. https://doi.org/10.67483/prj.v2.i1.23
Vancouver
Astuti AN, Kusumaeni T, Paramitha Y, Andriyanto DB, Nurhayati F. Cost-Effectiveness Analysis of Hemoptysis Therapies Among Hospitalized Patients at Persahabatan Hospital. Persahabatan Respirology Journal. 2026;2(1):44. doi:10.67483/prj.v2.i1.23
BibTeX
@article{Astuti2026,
author = {Astuti, Asri Nurfita and Kusumaeni, Tri and Paramitha, Yulia and Andriyanto, Dendhi Bagus and Nurhayati, Fitri},
title = {Cost-Effectiveness Analysis of Hemoptysis Therapies Among Hospitalized Patients at Persahabatan Hospital},
journal = {Persahabatan Respirology Journal},
year = {2026},
volume = {2},
number = {1},
pages = {44},
doi = {10.67483/prj.v2.i1.23}
}
EUVIMED